New Immunotherapy Advances Presented at the AACR Annual Meeting 2015

AACR Press Conference

Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial results that led to U.S. Food and Drug Administration (FDA) approvals …

Read More

Mastering the Clinical Development of Personalized Cancer Medicines


A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have been announced, and in some cases initiated, over the past few …

Read More